RecruitingNot ApplicableNCT07069101

Continuous Erector Spinae Block Versus Continuous Edge of Laminar Block on The Quality of Analgesia and Diaphragmatic Excursion in Patients With Multiple Rib Fractures

The Effect of Continuous Erector Spinae Block Versus Continuous Edge of Laminar Block on The Quality of Analgesia and Diaphragmatic Excursion in Patients With Multiple Rib Fractures. A Prospective Randomized Trail.


Sponsor

Tanta University

Enrollment

70 participants

Start Date

Nov 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This prospective randomized clinical trial aims to compare the effect of continuous erector spinae plane block versus continuous edge of laminar block on the quality of analgesia and diaphragmatic excursion in patients with unilateral traumatic multiple rib fractures.


Eligibility

Min Age: 21 YearsMax Age: 65 Years

Inclusion Criteria3

  • Aged between 21 and 65 years.
  • Both sexes.
  • With unilateral traumatic multiple fracture ribs (≥ 3), admitted to the surgical intensive care unit within the first day of trauma.

Exclusion Criteria10

  • Patients' rejection.
  • Body mass index ≥ 35 (kg/m2).
  • Bleeding and Coagulation disorders.
  • Known hypersensitivity to the study drugs.
  • Vertebral deformity.
  • Respiratory, cardiac, renal or hepatic dysfunction.
  • Patients with major trauma involving extra-thoracic structures (e.g., head, spine, pelvis, and abdominal visceral injuries).
  • Mental or cognitive dysfunction,
  • History of chronic analgesic or drug abuse.
  • Local infection at the site of the block.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERErector spinae block

Patients will receive continuous ipsilateral erector spinae plane block.

OTHEREdge of lamina block

Patients will receive continuous ipsilateral edge of laminar block.


Locations(1)

Tanta University

Tanta, El-Gharbia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07069101


Related Trials